baber/WOPTO huggingface dataset:
Patent CA-2670788-A1 (CA)
Title: A2a adenosine receptor antagonists
Inventor: KOBAYASHI TETSUYA
IPC: C07D495/04
Filed: 2007-11-29
Abstract: The present invention relates to novel compounds that are A2A adenosine receptor antagonists, and to their use in treating mammals for various disease states, such as CNS disorders, including the "movement disorders" (Parkinson's disease, Huntington's Chorea, and catalepsy), and cerebral ischemia, excitotoxicity, cognitive and physiological disorders, depression, ADHD, hepatic fibrosis, cirrhosis of the liver, and drug addiction (alcohol, amphetamine, cannabinoids, cocaine, nicotine, and opioids) and to their use in the enhancement of immune response. The invention also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them.
Patent CA-2672454-A1 (CA)
Title: Power aggregation system for distributed electric resources
Inventor: KAPLAN DAVID L
IPC: H04L12/28
Filed: 2007-12-11
Abstract: Systems and methods are described for a power aggregation system. In one implementation, a service establishes individual Internet connections to numerous electric resources intermittently connected to the power grid, such as electric vehicles. The Internet connection may be made over the same wire that connects the resource to the power grid. The service optimizes power flows to suit the needs of each resource and each resource owner, while aggregating flows across numerous resources to suit the needs of the power grid. The service can bring vast numbers of electric vehicle batteries online as a new, dynamically aggregated power resource for the power grid. Electric vehicle owners can participate in an electricity trading economy regardless of where they plug into the power grid.
Patent CA-2674059-A1 (CA)
Inventor: DEAGUERO JOEL
IPC: G11B27/02
Filed: 2007-12-26
Abstract: Systems, methods, and/or techniques ("tools") for optimizing execution of high- definition digital versatile disk (HD-DVD) timing markup are described herein. The tools may receive timing markup read from an HD-DVD disk, and optimize the processing of the timing markup using one or more of the optimization strategies described herein.
Patent CA-2674440-A1 (CA)
Inventor: PODOLSKI JOSEPH
IPC: A61K31/57
Filed: 2008-01-03
Abstract: Compositions with improved stability comprising a pharmaceutically acceptable salt of 11-(4-aminophenyl)-19-no.phi.regna-4,9(10)-diene- 3,20-dione derivatives are provided
Patent CA-2676934-A1 (CA)
Inventor: LACOUR LLOYD JOSEPH
IPC: G01V1/38
Filed: 2008-02-08
Abstract: A position controller capable of controlling the depth or lateral position of a towed array. The position controller comprises a tubular fuselage from which a pair of wings may be extended over a range of sweep angles between fully open and stowed positions. In fully or partly open positions, two wings present a positive angle of attack relative to the axis of the fuselage. In the stowed position, the wings are fully retracted into a wing receptacle within the fuselage for unfettered passage into and out of a submarine on the array deployment and retrieval handling system. The sweep angles of the two wings are independently adjustable by first and second actuators.
Patent CA-2679187-A1 (CA)
Inventor: HIGUCHI KENICHI
IPC: H04J11/00
Filed: 2008-02-19
Abstract: A base station device is used in a mobile communication system which employs the OFDM method for the downstream link. The base station device includes: means for creating a transmission signal by performing the inverse Fourier transform on a signal obtained by mapping the first signal and the second signal to a subcarrier with different transmission power densities; and means for transmitting the transmission signal to a user device. A subcarrier to which mapping of a second signal is inhibited (inhibited subcarrier) is decided so as to maintain the transmission power density of the second signal between a plurality of OFDM symbols, which does not depend on whether the OFDM symbol which contains the second signal also contains a first signal. The inhibit subcarrier is decided according to the subcarrier to which the first signal is to be mapped.
Patent CA-2679625-A1 (CA)
Title: Wheel assembly and dolly
Inventor: FERLAND MARC-ANDRE
IPC: B60G7/00
Filed: 2008-03-14
Abstract: A wheel assembly (12) for use in transporting material, the wheel assembly (12) having a frame (16) with a wheel (18) mounted thereon, and a first member (52) extending diagonally upwardly and outwardly from a bottom portion of the frame (16) when the wheel (18) is oriented in a vertical position. The wheel assembly (12) may be used in pairs as a dolly and pivotably connected together for carrying relatively heavy loads.
Patent CA-2680708-A1 (CA)
Title: Metal-binding therapeutic peptides
Inventor: MASCARENHAS DESMOND
IPC: C12N15/62
Filed: 2008-03-19
Abstract: Published without an Abstract
Patent CA-2681530-A1 (CA)
Title: Proteines liantes, y compris des anticorps, derives d'anticorps et fragments d'anticorps qui lient specifiquement cd154
Inventor: TAYLOR FREDERICK R
IPC: A61K39/395
Filed: 2008-03-21
Abstract: La présente invention concerne les protéines de liaison, incluant des anticorps, des dérivés d'anticorps et des fragments d'anticorps, qui se lient spécifiquement à une protéine CD154 (CD40L). Cette invention concerne en outre un anticorps, dérivé d'anticorps ou fragment d'anticorps chimérique, humanisé ou totalement humain, qui se lie spécifiquement à un épitope auquel un fragment Fab humanisé comprenant une séquence de chaîne lourde variable selon la séquence SEQ ID n° 1 et comprenant une séquence de chaîne légère variable selon la séquence SEQ ID n° 2 se lie spécifiquement. Les protéines se liant à CD154 de cette invention peuvent provoquer une fonction d'effecteur réduite par rapport à un second anticorps anti-CD154. Les protéines se liant à CD154 de cette invention sont utiles dans des procédés thérapeutiques et de diagnostic, tels que pour le traitement et la prévention de maladies incluant celles qui impliquent des réponses immunitaires indésirables qui sont médiées par les interactions CD154-CD40.
Patent CA-2683461-A1 (CA)
Inventor: SAUNDERS DEREK JOHN
IPC: C07D319/18
Filed: 2008-04-16
Abstract: The present invention relates to novel vanilloid receptor ligands, a method for the production thereof, pharmaceuticals containing said compounds, and the use of said compounds for the production of pharmaceuticals.
Patent CA-2683467-A1 (CA)
Title: Contact lens integrated with a biosensor for detection of glucose and other components in tears
Inventor: ZHANG JIN
IPC: A61B5/00
Filed: 2009-10-26
Abstract: The present invention provides contact lens with integrated biosensor for the continuous, non-invasive monitoring of physiological glucose by employing biocompatible nanostructure-laden lens materials. These contact lenses can be worn by diabetics who can colorimetrically see changes in their contact lens color or other fluorescence-based properties, giving an indication of tear and blood glucose levels. This invention for the glucose biosensor based on the new disposal contact lens provides a safe, convenient and non-expensive glucose sensing device. The sensing device disclosed herein provides an efficient and noninvasive solution for monitoring blood glucose.
Patent CA-2683895-A1 (CA)
Title: Method for making a flexible reclosable package
Inventor: PETERSON ROBERT J
IPC: B31B50/64
Filed: 2008-03-05
Abstract: A method of forming a flexible packaging laminate (30) that has a reclosa ble opening (20). The method includes forming a two-part laminate that has a n outer structure (40) joined in face-to-face relation with an inner structu re (60). Score lines (122,142) are formed in both structures (40,60) to enab le an opening to be formed through the laminate by lifting an opening portio n (e.g., a flap or the.like) of the two structures out of the plane of the l aminate.. The score line (122) through the outer structure defines a larger opening than the score line (142) through the inner structure, such that a m arginal region of the outer structure extends beyond the edge of the opening portion of the inner structure. A pressure-sensitive adhesive (92) is used to re-adhere the marginal region to an underlying surface of the inner struc ture adjacent the opening through the laminate.
Patent CA-2684788-A1 (CA)
Inventor: SCHNEIDER JOHN K
IPC: H01L41/00
Filed: 2008-04-21
Abstract: A device for scanning a biological object, such as a fingerprint, is disclosed. One such device includes an array of acoustic waveguides and a piezoelectric array device. The piezoelectric array devices may be arranged in association with the waveguide array to provide ultrasonic energy in the form of an ultrasonic wave or collection of waves to the waveguide array, and also arranged to receive ultrasonic energy in the form of an ultrasonic wave or collection of waves from the waveguide array. The acoustic energy received by the piezoelectric array from the waveguide array may be energy that has been reflected from the biological object. A waveguide array according to the invention uses internal reflection to transmit the acoustic wave from one end of the waveguide array to another end of the waveguide array.
Patent CA-2686865-A1 (CA)
Inventor: MILLS ROBERT ARTHUR
IPC: B66C1/66
Filed: 2008-04-30
Abstract: A head block assembly (105) comprising a first head block (120) having a first pair of cable engaging sheaves (130); a second head block (125) having a second pair of cable engaging sheaves (135); a separation device (140) mounted intermediate the first and second head blocks (120, 125), for effecting relative transverse movement of said head blocks; wherein the first pair of sheaves (130) are selectively disengagable from the first head block (120), and selectively engagable with the second head block (135).
Patent CA-2690001-A1 (CA)
Inventor: CAULFIELD THOMAS J
IPC: A61P29/00
Filed: 2008-06-04
Abstract: The present invention relates to A compound of the formula Ia wherein in any of its stereoisomers forms or a mixture of stereoisomeric forms in any ratio, or a physiologically acceptable salt thereof, wherein the substituents are as described herein. The inventive compounds have CXCR5 inhibitory activity are particularly useful in treating or preventing various inflammatory diseases, such as rheumatoid arthritis, multiple sclerosis, lupus, Crohn's Disease, associated with the modulation of the human CXCR5 receptor.
Patent CA-2690302-A1 (CA)
Inventor: GIDEONI IFTAH
IPC: B60W40/00
Filed: 2004-10-22
Abstract: Methods and apparatus are provided for command and control of an unmanned vehicle ("UV"). A preferred embodiment of the invention includes a Virtual Pilot ("VP"), which includes a Brain and an Arena. The Brain includes rules governing the behavior of the UV and information on missions to be performed. The Arena includes state information about the UV and its environment. UVs in a swarm communicate with each other, as well as with various ground stations, through regular updates. Backup schemes are provided to deal with the failure of a UV module, thereby providing partial degradations in performance. Communication among the UVs and ground stations of a system employ a probabilistic scheme that promotes high spectral efficiency.
Patent CA-2690593-A1 (CA)
Title: Inhibiteurs de tace dans le traitement de l'acne
Inventor: AUBERT JEROME
IPC: G01N33/573
Filed: 2008-06-18
Abstract: L'invention concerne une méthode in vitro de criblage de composés candidats pour le traitement préventif ou curatif de l'acné, comprenant la détermination de la capacité d'un composé à inhiber l'expression ou l'activité de TACE, ainsi que l'utilisation d'inhibiteurs de l'expression ou de l'activité de cette enzyme pour le traitement de l'acné.
Patent CA-2696280-A1 (CA)
Inventor: SCHRAER THORSTEN
IPC: B60R19/18
Filed: 2008-07-24
Abstract: The invention relates to a device for fastening plastic parts (10) to a motor vehicle body (12), having an internal thread (14) which is formed on the body (12) and having a screw (16) which has an external thread (18) and which is provided with an oversized head (20), which screw (16) is inserted into the internal thread (14), wherein a cylindrical sleeve (22) is placed between the screw head (20) and the body (12), the inner diameter of which cylindrical sleeve (22) is significantly larger than the outer diameter of the external thread (18) of the screw (16), and wherein a cylindrical sleeve (24) is attached coaxially, by means of its inner edge which faces toward the body (12), to the outer edge, which faces away from the body (12), of the sleeve (22), the inner diameter of which cylindrical sleeve (24) forms a fit with the outer diameter of the sleeve (22), and which cylindrical sleeve (24) ends, at its body-side end, in an outwardly extending disk (26), the outer diameter of which corresponds approximately to the outer diameter of the screw head (20), wherein an opening (28) for receiving the device is provided in the plastic part (10), the inner diameter of which opening (28) is larger than the outer diameter of the sleeve (24) but smaller than the outer diameter of the flat washer or of the oversized screw head (20) and of the disk (26) which is attached to the sleeve (24).
Patent CA-2701062-A1 (CA)
Inventor: VELIKOV JORDAN
IPC: A61B17/84
Filed: 2008-09-26
Abstract: The invention relates to a bone anchoring device (10; 11) for the operative repair of fractures, comprising a fracture fixation plate (20; 21; 56) which has at least one opening (22) and at least one anchoring element for the fastening of the fracture fixation plate on the bone, wherein the anchoring element has a shaft and a head (26, 27; 60), and wherein at least one part of the shaft can be guided through the opening while the head can be fixed in the opening, and wherein the shaft is produced in at least two parts with a first part (12, 13, 40, 44, 48; 52) on which the head is arranged and with a second part provided for the anchoring in the bone (14; 54), wherein the first part and the second part of the shaft are guided such that they move toward each other along an axis when the bone anchoring device is in the state of being fixed to the bone.
Patent CA-2705025-A1 (CA)
Inventor: PAGANINI LIVIO
IPC: B65B25/14
Filed: 2008-11-04
Abstract: The device comprises a stacking surface (3) movable in a substantially vertical direction, on which layers (S1, S2, S3) of products (P) to be packaged are superposed, and a pair of conveyors (7, 9) substantially superposed to feed the layers of products to the stacking surface. The device also comprises a pair of walls (31A, 31B) substantially parallel, and substantially vertical, between which the layers of products are inserted by the conveyors when they are stacked on the stacking surface. The walls move reciprocally towards and away from each other to take a position of greater reciprocal distance, in which they do not interfere with the products deposited on the stacking surface, and a position of lesser reciprocal distance, in which they interfere with the products inserted therebetween.
Patent CA-2705628-A1 (CA)
Inventor: VINCI LUCA
IPC: A61M1/34
Filed: 2008-12-16
Abstract: A medical apparatus (100) for extracorporeal blood treatment comprises a support structure (101) housing a hydraulic circuit (1) located above a liquid collection zone (103) such that liquid losses from the hydraulic circuit can at least partially accumulate at the liquid collection zone. A  liquid sensor (108) detects presence of any liquid in the liquid collection zone and operates in a distanced position with respect to the liquid collection zone (103).
Patent CA-2706672-A1 (CA)
Title: Modulateurs de egr1 dans le traitement de l'alopecie
Inventor: RETHORE SANDRINE
IPC: C12Q1/68
Filed: 2008-11-26
Abstract: L'invention concerne une méthode in vitro de criblage de composés candidats pour le traitement préventif ou curatif de l'alopécie, comprenant la détermination de la capacité d'un composé à moduler l'expression ou l'activité du facteur de transcription Early Growth Response 1 (EGRl), ainsi que l'utilisation de modulateurs de l'expression ou de l'activité de ce facteur de transcription pour le traitement de l'alopécie. L'invention concerne aussi des méthodes de diagnostic ou pronostic in vitro de cette pathologie.
Patent CA-2707389-A1 (CA)
Inventor: SONNENMOSER ASTRID
IPC: B66B1/34
Filed: 2008-07-04
Abstract: The monitoring method of a lift installation comprises a control unit (11) and at least one bus junction (13), which bus junction (13) comprises a receiver (14), a transmitter (15) and a safety element (16). The control unit (11)and the bus junction (13) communicate by way of a bus (12). The monitoring method has the following steps: a digital default signal is transmitted by the control unit (11) to the receiver (14); the digital default signal is converted by the receiver (15) into an analog signal; the safety element (16) is acted on (16.1) by the receiver (14) with the analog signal; if the safety element (16) is closed the analog signal is detected (16.2) by the transmitter (15); for a detected analog signal, a digital signal of the control unit (11) is provided by the transmitter (15);  wherein on detection of an analog zero signal a digiital signal is transmitted by the transmitter (15) to the control unit (11).
Patent CA-2707736-A1 (CA)
Inventor: MAUTINO PETER S
IPC: B61G3/06
Filed: 2005-07-29
Abstract: A railcar coupler knuckle comprises a tail section, a hub section and a face section. The hub section has a pivot pinhole formed therein which has generally straight cylindrical sidewalls. A front face section is connected to the hub section and includes a nose section and a pulling face portion formed inwardly from the nose section. At least a portion of the pulling face portion includes an enhanced bearing surface area which includes a substantially flat portion disposed substantially in a vertical direction and which is substantially arcuate in a horizontal direction. The substantially flat portion of the enhanced bearing surface area has a configuration corresponding to a configuration of a portion of a manufacturing core.
Patent CA-2708352-A1 (CA)
Inventor: GRAINGER DAVID JOHN
IPC: A61K31/4015
Filed: 2008-12-10
Abstract: The invention relates to the use of Broad-Spectrum Chemokine Inhibitors (BSCIs), and in particular members of the acylaminolactam class of pharmaceutical agents, for the prevention, prophylaxis, treatment or amelioration of symptoms of inflammatory diseases. In particular, improved compositions consisting of BSCI  agents combined with one or more additional active pharmaceutical agents in order to achieve improved anti- inflammatory efficacy with a reduced side-effect profile are described and claimed.
Patent CA-2709367-A1 (CA)
Inventor: HARRIS PAUL
IPC: C07K14/39
Filed: 2008-12-17
Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Patent CA-2711465-A1 (CA)
Inventor: JI TINGFANG
IPC: H04W16/14
Filed: 2009-01-28
Abstract: Providing for virtual management of wireless re-sources in a mobile communication environment is described herein. By way of example, access terminals in the communica-tion environment can maintain connections with nearby net-work transmitters and report factors pertinent to wireless scheduling to a central entity, such as a macro base station. The macro base station can employ those factors in improving wire-less communications for other serving cells within or near to a macro coverage area served by the macro base station. By main-taining information pertinent to prevailing wireless conditions, quality of service requirements, pilot signal reports, mobility management considerations, and so on, of transmissions within the cell, significant interference reduction can be implemented for the macro coverage area, or nearby coverage areas.
Patent CA-2721791-A1 (CA)
Inventor: NARDELLI DAVIDE
IPC: H01R4/68
Filed: 2009-04-16
Abstract: A superconducting joint that structurally binds a first superconducting segment to a second superconducting segment. The first and second superconducting segment each include corresponding areas containing a granular superconducting sub-stance formed by a first element and a second element. The superconducting joint includes a solid non-superconducting binding formed from a source of the first element and a source of the second element combined to produce the granular superconducting substance around the solid non- superconducting binding to permit for the flow of superconducting current through the first super-conducting segment and the second superconducting segment.
Patent CA-2722370-A1 (CA)
Inventor: BARNES DARRYL E
IPC: A61B17/50
Filed: 2009-02-20
Abstract: Systems, devices and methods to access and/or treat targeted body tissue (e.g., tendon tissue, liga-ment tissue, muscle tissue, bony tissue, and the like) under the guidance of ultrasound imaging equipment are de-scribed. Such systems can permit the intra-operative identi-fication of the targeted tissue and the ability to deliver the appropriate instrumentation to that tissue.
Patent CA-2722621-A1 (CA)
Inventor: CARNEY DARRELL H
IPC: A61P21/02
Filed: 2009-03-24
Abstract: Agonists of a non-proteolytically activated thrombin receptor, and more particularly, thrombin peptide derivatives, can be used in methods to cause smooth muscle relaxation. Compositions comprising thrombin peptide derivatives can be administered to a subject with a disease or disorder that can be ameliorated by relaxation of smooth muscle. Such compositions can also be administered to a subject to facilitate medical, diagnostic or surgical procedures.
Patent CA-2724021-A1 (CA)
Title: Transportable buildings
Inventor: HERMAN ALVIN
IPC: E04B1/343
Filed: 2010-12-06
Abstract: A transportable building apparatus has an elongated enclosure with a front, rear and end walls having wall truss structures with a top wall beam, a bottom wall beam, and a wall web comprising a plurality of web boards forming a plurality of triangles. The web boards are oriented on edge such that a maximum thickness of the wall truss structure is equal to a thickness of one of the web boards, the top wall beam, and the bottom wall beam. An insulated covering is attached to exterior faces of the wall truss structures.  Conveniently structural insulated panels with a rigid insulating layer sandwiched between exterior and interior rigid sheets could be used, with the rigid interior sheet attached to the exterior face of the truss structures. A four point mounting system can facilitate handling and installation of the apparatus, and a transport cradle reduces building stresses during transport.
Patent CA-2726803-A1 (CA)
Title: Variant alpha-amylases from bacillus subtilis and methods of use, thereof
Inventor: CHIN REGINA
IPC: C12N9/28
Filed: 2009-06-05
Abstract: Alpha amylases from Bacillus subtilis (AmyE), variants thereof, nucleic acids encoding the same, and host cells comprising the nucleic acids are provided. Methods of using AmyE or variants thereof are disclosed, including liquefaction and/or saccharification of starch. Such methods may yield sugars useful for ethanol production or high fructose corn syrup production. In some cases, the amylases can be used at low pH, in the absence of calcium, and/or in the absence of a glucoamylase.